Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
236 Cards in this Set
- Front
- Back
Bcl2
|
Chromosome 18
On mitochondrial membrane Anti-apoptotic protein Bax homodimer can bind to it and promote apoptosis Promoter interacts with EBV LMP See in follicular lymphoma (except 50% of grade 3 and not in the primary cutaneous version). Can be useful for distinguishing reactive from neoplastic germinal centers. |
|
Bcl6
|
Chromosome 3
Expressed in germinal centers Expressed in some intrafollicular CD4 T cells Positive in 30-80% of large cell lymphomas |
|
CD43
|
Pan T cell marker
Use to diagnose granulocytic sarcoma, can be positive in anaplastic large cell lymphoma |
|
Pax-5
|
Marks pro-B cells to plasma cells
Stains 97% of reed-sternberg cells Positive in most B cell malignancies Also positive in lymphoplasmacytic lymphoma, Merkel carcinoma, and small cell carcinoma |
|
Follicular lymphoma translocation/gene?
|
t(14;18)
Bcl2 gene involvement? |
|
Grading of follicular lymphoma?
|
Based on proportion of centroblasts.
Grade 1: <6 per hpf Grade 2: 6-15 per hpf Grade 3: >15 per hpf Have to count 10 hpf in 10 follicles. |
|
Grade of most follicular lymphomas?
|
Grade 1 or 2 (80-90%)
|
|
Grade of most pediatric follicular lymphomas?
|
Low grade, but are more likely to be grade 3 than adults.
|
|
Mum1?
|
Post-germinal center transcription factor. Expressed by late centrocytes, but negative in follicular lymphoma.
Poor prognostic marker in DLBCL. |
|
Antibodies used to detect follicular dendritic cells?
|
CD21 and CD23
|
|
What can normally express Bcl-2?
|
T cells, primary follicles, and mantle zones.
|
|
Bcl6 and Mum1 relationship
|
Should be mutually exclusive in normal germinal centers. Co-expression can be seen in DLBCL.
|
|
DLBCL and immunosuppression?
|
Often EBV positive.
|
|
Common chromosomal translocations in DLBCL?
|
30% involve 3q27 (bcl-6). 20-30% involve bcl-2.
|
|
Lymphomatoid granulomatosis, ke words:
|
Angiocentric and angiodestructive.
EBV positive |
|
Kimura disease?
|
Reactive follicular hyperplasia, cortical and paracortical eosinophilia, and cortical and paracortical hypervascularity. Polykaryocytes.
IgE can cause nephortic syndrome, can see proteinaceous stuff in the germinal centers. |
|
Angioimmunoblastic T-cell lymphoma
|
Systemic.
Lymph nodes show a polymorphous infiltrate and proliferation of high endothelial venules. Constant association with EBV. In 75% of cases, EBV positive B cell expansion (immunoblasts in the paracortex) and FDCs (surrounding HEVs). Paracortical. Immuno: T cell markers, usually CD4. CD10, CXCL13, PD1. Trisomy 3, trisomy 5, additional X chromosome |
|
Kikuchi Histiocytic Necrotizing Lymphadenitis
|
Young asian women.
Excellent prognosis. Three phases: proliferative phase, with bizarre histiocytes eating apoptotic debris. necrotic phase. Resolution phase- foamy macrophages. |
|
Rosai-Dorfman
|
Sinus histiocytosis with massive lymphadenopathy. More common in black people. 40% of cases have extranodal involvement. S100 useful stain (very positive). Emperipolesis.
|
|
Primary effusion lymphoma.
|
Large B cell neoplasm.
Doesn't make a mass initially. Immunodeficient patients. HHV8 positive. Co-infection with EBV. CD45+, but lack pan-B cell markers (CD19, CD20, CD79a, IIg), other things can be positive (CD38, CD138, HLA-DR, CD30). May aberrantly express T cell markers (often causes problems immunophenotyping the cells). Bad prognosis- 6 months. |
|
Plasmablastic lymphoma
|
immunoblast lymphoma, but stains like plasma cells.
HIV+, often in oral cavity or other mucosal sites. EBV+. usually negative for CD45, CD20, pax5. CD56 + should make you think of underlying myeloma. EMA and CD30 often +. Ki67 is high. Bad prognosis. |
|
Autoimmune disease in lymph nodes?
|
Reactive follicular hyperplasia, plasma cell proliferation, and neutrophils in the sinuses.
|
|
Toxoplasmosis in lymph node?
|
Reactive follicular hyperplasia, small poorly formed granulomas within germinal centers is fairly specific, and monocytoid B cell hyperplasia.
Most common site is posterior cervical. The organism is rarely seen by exam or by genomic PCR. |
|
Hyaline-vascular Castleman disase?
|
Young people, asymptomatic. Mediastinal mass. Onion-skinning mantle zone around multiple germinal centers. Abnormal follicular dendritic cells.
Most common type. |
|
Unicentric plasma cell Castleman disease?
|
B symptoms. Elevated IL-6. Surgical excision is curative. Looks like: lots of plasma cells in the paracortex. Can be monotypic.
|
|
Multicentric Castelman disease?
|
Older people, HIV. POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monocloncal gammopathy, skin). All patients with HIV have HHV8. Plasmablastic lymphoma can arise from.
|
|
lymphoplasmacytic lymphoma.
|
lymphoma of small B cells, plasmacytoid B cells, and plasma cells. Usually with waldenstroms. Can be HCV related. Usually involves BM, lymph node sinuses.
|
|
Waldenstrom's =?
|
lymphoplasmacytic lymphoma with bone marrow involvement, IgM paraprotein
|
|
Dutcher body?
|
PAS+ intranuclear inclusion in lymphoplasmacytic lymphoma.
|
|
Poor prognosis in lymphoplasmacytic lymphoma?
|
Old, cytopenias, high beta-2-microglobulin.
|
|
Staining for Langerhan's giant cells?
|
+ S100, CD1a
- CD68 |
|
What kind of T cells in T-prolymphocytic leukemia?
|
Post-thymic T cells.
|
|
Leukemia with cytoplasmic blebs?
|
Could be T-cell prolymphocytic leukemia.
|
|
T-prolymphocytic leukemia in the skin?
|
Perivascular or diffuse dermal infiltrates without epidermotropism.
|
|
CD52 and T-prolymphocytic leukemia?
|
Usually expressed at a high density and can be used as a target of therapy (monoclonal antibody)
|
|
TCL-1?
|
Onocgene overexpressed by T-cell prolymphocytic leukemia. Can do IH for. Can be a prognostic factor.
|
|
Pro-lymphocytic leukemia: Cd4 or CD8?
|
60% are CD4, 25% are double positive.
|
|
Most common cytogenetic abnormality in T-PLL?
|
inv(14), abnormalities of 8, deletions at 12
|
|
What is T-LGL leukemia?
|
Persistent increase in PB LGLs (2-20x10^9)
|
|
In what other clinical scenarios can you see clonal expansion of T-LGLs?
|
Post-stem cell tx, PTLD, low-grade B cell malignancies (hairy cell, CLL).
|
|
Other disease associations for T-LGL leukemia?
|
Rheumatoid arthritis, underlying malignancy (if CD34+)
|
|
Helpful IH in T-LGL leukemia?
|
TIA1, granzyme B
|
|
Prognosis of T-LGL leukemia?
|
indolent, but morbidity d/t NEUTROPENIA.
|
|
CD3 in NK cells? CD5?
|
Only cytoplasmic CD3, not surface. CD5 is negative.
|
|
EBV and chronic lymphoproliferative disorder of NK cells? Course?
|
Not related. Usually indolent course.
|
|
Who gets aggressive NK-cell leukemias?
|
Young asians
|
|
Associated virus with aggressive NK-cell leukemia?
|
EBV
|
|
Oblique method to establish clonality in NK cell lesions?
|
For females, pattern of X inactivation.
|
|
Course of aggressive NK cell leukemia?
|
Fulminant. Coagulopathy, hemophagocytic syndrome, multiorgan failure.
|
|
Two major types of EBV-associated LPD or childhood?
|
1) Hydroa vacciniforme: an indolent cutaneous malignancy.
2) Systemic EBV+ LPD: fulminant, preceded by a prodromal phase of polyclonal expanstion of EBV-infected T cells. |
|
What ethnicity of children get EBV-associated LPD?
|
Asian, native american.
|
|
Etiology of hydroa vacciniforme?
|
Neoplastic T (sometime NK) cells invade superficial dermis of sun-exposed areas. Angiocentric and angioinvasive. Epidermis shows pustules and ulceration
|
|
Mosquite bite hypersensitivity?
|
Associated with EBV-associated LPD of childhood, hydrao vacciniforme type.
|
|
Systemic EBV+ T-cell LPD of childhood?
|
Clinically similar to aggressive NK cell leukemia. But it's in the T cells. Marked hemophagocytosis. Liver failure, coagulopathy.
|
|
Where do you see endemic ATLL?
|
Japan, carribbean, and central Africa.
|
|
What % of HTLV-a infected inviduals will develop ATLL?
|
2.5%
|
|
Most common extra-lymphatic site of involvement for ATLL?
|
Skin (erythema, papule, nodule). It's a systemic disease.
|
|
What is the most common clinical variant for ATLL?
|
Acute (leukemia phase, lymphadenopathy, skin involvement).
|
|
Clinical association with ATLL?
|
Hypercalcemia, T cell immunodeficiency (can see opportunistic infections, like PCP and cryptococcal meningitis).
|
|
Cytology of ATLL?
|
A variety (small, medium, large cell, anaplastic, etc). Can look like other lymphomas, too (Hodgkins, angioimmunoblastic).
|
|
Characteristic PB cell in ATLL?
|
Plylobated nuclei of flower cell.
|
|
CD4 or CD8 for ATLL? Other characteristic expression?
|
Most cases are CD4+. Express like regulatory T cells: CD25 and FOXP3
|
|
Gene of HTLV-a that is central leukemogenesis?
|
Tax.
|
|
A clever way to monitor disease in extranodal NK/T cell lymphoma, nasal type?
|
Measure circulating EBV DNA.
|
|
Histologic features of NK/T cell lymphoma? Cytology?
|
Ulceration, necrosis. Can be angiodestructive. Glands are surrounded and show clear cell change.
Cytology is pretty variable, can see small, medium, large, or anaplastic cells. |
|
CD56 and extranodal NK/T cell lymphoma?
|
Not sensitive or specific. Need to see the EBV positivity to call. If EBV negative, then consider T-cell lymphoma, NOS
|
|
What kind of enteropathy-associated T cell lymphoma can occur without celiac disease?
|
Monomorphic variant (type II)
|
|
Most common site(s) for enteropathy-associated T cell lymphoma?
|
Jejunum or ileum
|
|
HLAs associated with enteropathy-associated T cell lymphoma?
|
HLA DQ2 and DQ8
|
|
Immunophenotype of cells in enteropathy-associated T cell lymphoma?
|
CD4 NEGATIVE, CD8 +/-, CD5-, CD3+
|
|
Genotype of people with celiac disease?
|
HLADQA1, HLADQB1
|
|
Precursor lesion of enteropathy-associated T cell lymphoma?
|
Refractory celiac disease with abnormal intraepithelial lymphocytes.
|
|
Prognosis of enteropathy-associated T cell lymphoma?
|
Not good- ulcerations, perforations, and the patient is already malnourished.
|
|
Who gets hepatosplenic T cell lymphoma?
|
Young (adolescent to early adult) males.
|
|
Sites of involvement for hepatosplenic T cell lymphoma?
|
Liver, spleen, bone marrow... not so much lymph nodes or skin.
|
|
TCR associated with hepatosplenic T cell lymphoma?
|
gammadelta.
|
|
Disease association with subcutaneous panniculitis-like T cell lymphoma?
|
20% have autoimmune disease (like lupus).
|
|
Subcutaneous panniculitis-like T cell lymphoma vs. lupus panniculitis?
|
Lupus panniculitis has plasma cells, and usually other inflammatory cells are absent with the lymphoma.
|
|
Kind of T cells involved in subcutaneous panniculitis-like T cell lymphoma?
|
CD8 alphabeta T cells.
|
|
Features of subcutaneous panniculitis-like T cell lymphoma?
|
Nodules on trunk and extremities. No ulceration but frequent necrosis (can see foamy histiocytes of fat necrosis). Often neoplastic cells will rim individual adipocytes.
|
|
Most common cutaneous T cell lymphoma?
|
Mycosis fungoides
|
|
Clinical stages of MF?
|
Patch, plaque, tumor.
|
|
Lymph node involvement of patients with MF?
|
Enlarged LNs frequently show dermatopathic lymphadenopathy with paracortical expansion due to histiocytes. Increasing presence of cerebriform lymphocytes with increasing stage.
|
|
MF and CD7?
|
It is typically negative.
|
|
Most important prognostic factor in MF?
|
Clinical stage: the extent of cutaneous and extracutaneous disease.
|
|
Prognosis of folliculotropic MF?
|
Worse than regular.
|
|
Triad of sezary syndrome?
|
erythroderma, generalized lymphadenopathy, and clonally-related T cells with cerebriform nuclei in skin, lymph nodes, and peripheral blood.
|
|
Additional requirements for Sezary syndrome with the triad?
|
An absolute Sezary count of at least 1000 cells per mm3, CD4/CD8 ratio of more than 10, and loss of one or more T cell antigens.
|
|
BM in Sezary syndrome?
|
Often a remarkable sparing, despite disseminated disease.
|
|
Granulomatous slack skin?
|
An extremely rare subtype of cutaneous T cell lymphoma like MF
|
|
Pagetoid reticulosis?
|
An intraepidermal cutaneous T cell lymphoma like MF.
|
|
Second most common group of cutaneous T cell lymphomas (after MF)? Second most common type?
|
Primary cutaneous CD30-positive T cell lymphoproliferative disorders. Primary cutaneous anaplastic large cell lymphoma is second most common after MF.
|
|
What is included in the CD30 positive T cell lymphoproliferative disorders?
|
Cutaneous anaplastic large cell lymphomas and lymphomatoid papulosis, and borderline cases. A spectrum.
|
|
Differential diagnosis of primary cutaneous large cell lymphoma?
|
Systemic anaplastic large cell lymphoma with skin involvement, Transformed MF.
|
|
Histology of primary cutaneous anaplastic large cell lymphoma?
|
Usually non-epidermotropic infiltrates with cohesive sheets of large CD30 positive tumor cells.
|
|
Prognosis of primary cutaneous anaplastic large cell lymphoma?
|
Surprisingly good.
|
|
Lymphomatoid papulosis?
|
Chronic, recurrent, self-healing skin disease with large anaplastic (cerebriform or Hodgkin like cells) cells in the skin with a marked inflammatory background.
|
|
3 types of histologic pictures of lymphomatoid papulosis?
|
A, B, and C. A has the least atypical cells with mostly inflammation, and C is mostly atypical cells. B looks kind of like MF. Type B is CD30 negative!
|
|
Peripheral T cell lymphomas, NOS?
|
Account for 30% of peripheral T cell lymphomas in western countries in adults.
|
|
Immunophenotype of peripheral T cell lymphoma, NOS?
|
Usually CD4+, loss of CD5, 7, and/or 2.
|
|
3 special variants of peripheral T cell lymphoma, NOS?
|
1) Lymphoepithelioid variant (lots of epithelioid histiocytes), 2) follicular varaint (can look like follicular lymphoma), and 3) T-zone (can be mistake for benign paracortical expansion)
|
|
Features of angioimmunoblastic T cell lymphoma?
|
1) A peripheral T cell lymphoma with systemic disease, involving lymph nodes, and 2) a prominent proliferation of high endothelial venules and follicular dendritic cells.
|
|
Viral association of angioimmunoblastic T cell lymphoma?
|
EBV, but neoplastic T cells are EBV negative.
|
|
Angioimmunoblastic T cell lymphoma and B cells?
|
In 75% of cases, there is an expansion of EBV positive B cells.
|
|
Cytology in angioimmunoblastic T cell lymphoma?
|
Small to medium sized cells with cleared cytoplasm. Can see RS like cells
|
|
B cell danger in angioimmunoblastic T cell lymphoma?
|
Can progress to EBV positive diffuse large B cell lymphoma.
|
|
Phenotype of T cells in angioimmunoblastic T cell lymphoma?
|
Like follicular helper T cells: positive for CD3, CD10, and CXCL13
|
|
Prognosis of angioimmunoblastic T cell lymphoma?
|
Not good. Most die within 3 years.
|
|
Most ALCL, ALK+ happens in?
|
Young people.
|
|
ALCL, ALK+ accounts for what percentage of childhood lymphomas?
|
10-20%
|
|
Most patients with ALCL, ALK+ present in?
|
High stage disease (lymphadenopathy, extranodal site involvement)
|
|
Hallmark cell in ALCL, ALK+?
|
Large with horseshoe or kidney shaped nucleus with an eosinophilic aread next to the nucleus.
|
|
Patterns of ALCL, ALK+?
|
Common (can see anaplastic cells in the sinuses, like a metastatic tumor), lymphohistiocytic, small cell (can look signet or fried egg), Hodgkin-like (can look like nodular sclerosis), mixed.
|
|
ALK is on what chromosome? Where is it normally expressed in the body?
|
Chr 2. Not expressed in any postnatal tissue, except for rare cells in the brain.
|
|
Staining pattern of CD30 in ALCL, ALK+?
|
Cell membrane and golgi regions.
|
|
Immunohistochemical features of ALCL, ALK+?
|
Negative for CD3 (!).
ALK+, CD30+, EMA+. Strongly positive for CD25. Also for cytotoxic markers, TIA and granzymeB |
|
Cytoplasmic granular ALK staining?
|
Diffuse large B cell lymphoma with immunoblastic/plasmablastic features.
|
|
Most frequent genetic aberration in ALCL, ALK+?
|
t(2;5) nucleophosphmin-ALK
|
|
Overall 5-year survival of ALCL, ALK+? ALK-?
|
80%,
48% |
|
Clinical differences between ALK- and ALK+ ALCL?
|
ALK- peeps are older and worse prognosis. Cells are uglier.
|
|
Hodgkin lymphoma accounts for what % of all lymphoma?
|
30
|
|
Staging for Hodgkin lymphoma?
|
I one site (LN or lymphatic tissue)
II. More sites, same side of diaphragm III. Both sides of diaphragm (III2, vessel nodes) IV. Extranodal site |
|
2 main types of Hodgkin lymphoma?
|
Nodular lymphocyte predominant and classical Hodgkin lymphoma
|
|
4 types of Classical Hodgkin lymphoma?
|
Nodular sclerosis, mixed cellulariy, lymphocyte depleted, and lymphocyte rich
|
|
"popcorn" cells?
|
L and H cells, nodular lymphocyte predominant hodgkin lymphoma?
|
|
What does nodular lymphocyte predominant Hodgkin lymphoma look like?
|
Nodules in the lymph node of small lymphocytes, histiocytes, and L&H cells.
|
|
Popcorn cells stain...
|
+cd20, cd79a, oct2, bob1.
Negatvie for cd15 and cd30 |
|
Ring of t lymphocytes around a bigger cell?
|
Hodgkin lymphoma
|
|
architectural pattern of nlphl?
|
Large spherical networks of dendritic cells.
|
|
Who gets nlphl and prognosis?
|
Young men, and good prognosis
|
|
Percentage of hodgkin's lymphomas that are classical type?
|
95%
|
|
Who gets Classical Hodgkin lymphoma?
|
bimodal peak (15-35) and later in life
|
|
EBV is linked to what kinds of hodgkin lymphoma?
|
mixed cellularity type and lyphocyte depleted
|
|
Anatomic site most frequently involved by classic Hodgkin lymphoma?
|
Cervical lymph nodes (75%) of cases
|
|
Splenic involvement by classic Hodgkin lymphoma is associated with what?
|
An increased risk of extranodal dissemination.
|
|
Subtype of Hodgkin lymphoma most likely to be found in the mediastinum?
|
Nodular sclerosis
|
|
Mummified cell?
|
A Reed-Sternberg cell that has condensed cytoplams and pyknotic reddish nuclei.
|
|
Lacunar cell?
|
Nodular sclerosing Hodgkin lymphoma.
|
|
Interesting staining pattern of RS cells? Best B cell marker for RS cells?
|
CD30+, CD15 usually +, CD45 negative. Mum1 intensely +. Pax5 is best B cell marker.
|
|
Oct2 and Bob1 in RS cells?
|
Usually both are absent
|
|
What % of Classical Hodgkin lymphoma is curable?
|
85
|
|
How many nodules do you need to call it nodular sclerosis CHL?
|
Just one
|
|
Mixed cellularity CHL?
|
Looks like nodular sclerosis, except no sclerosis. Cases that dont fit the other types are put in this category.
|
|
Rarest CHL subtype?
|
lymphocyte-depleted
|
|
Common cytogenetic abnormalities seen in CLL?
|
trisomy 12, del 11q23(bad prognosis), del 13q14
|
|
Bad prognosis things in CLL?
|
High CD38, p53, unmutated IgH, deletions of 17p and 11 q.
|
|
Things that affect the red pulp of the spleen?
|
Hairy cell leukemia, T-LGL, hepatosplenic T cell lymphoma. Also, histiocytoses, extramedullary hematopoiesis,
|
|
Translocations in Burkitt lymphoma?
|
t(8;14)
t(2;8) t(8;22) |
|
How do you tell the difference between T-cell rich large B cell lymphoma and nodular lymphocyte predominant HL?
|
You only hae to find one nodule- NLPHL can have a very diffuse architecture, so do a follicular dendritic cell marker to find the nodules.
|
|
L&H cells tend to be ringed by what?
|
CD3 positive T cells.
|
|
Oct2/Bob1?
|
Positive in LH cells, but negative in most RS cells.
|
|
What percent of nodular sclerosing HOdgkin lymphomas involve the mediastinum?
|
80%
|
|
Where does lymphocyte-depleted Hodgkin's lymphoma like to be?
|
In the retroperitoneal lymph nodes or abdominal organs.
|
|
Which Hodgkin's lymphoma could be mistaken for DLBCL?
|
Classical, lymphocyte depleted. It has mostly large Reed-Sternberg cells.
|
|
Common clinical for hairy cell leukemia?
|
Older (50ish) white male with pancytopenia.
|
|
CD25?
|
For hairy cell and systemic mastocytosis. Also adult T cell leukemia/lymphoma is usually positive.
|
|
Hematologic malignancy with the highest familial predisposition?
|
CLL
|
|
What does Zap-70 tell you?
|
It is a surrogate for the mutational status of CLL. Zap70 positive is associated with unmutated (worse prognosis).
|
|
Danger of CLL?
|
10% develop DLBCL
|
|
How does B-prolymphocytic leukemia present?
|
B symptoms, massive splenomegaly, and a rapidly rising white count.
|
|
Circulating villous lymphocytes?
|
splenic marginal zone lymphoma
|
|
What does splenic marginal zone lymphoma look like?
|
Nodules in the white pulp surrounding germinal centers with marginal zones of larger pinker cells surrounding the nodules.
|
|
Cytogenetics in splenic marginal zone lymphoma?
|
Not t(11;18). Loss of 7q more common.
|
|
Monocytopenia?
|
Characteristic of hairy cell leukemia.
|
|
Morphology of hairy cell leukemia in the spleen?
|
Fried egg appearance.
|
|
Characteristic cytochemistry for hairy cell leukemia?
|
Tartrate-resistant acid phosphatase (TRAP) positivity
|
|
Most specific marker for hairy cell leukemia?
|
Annexin A1- not expressed by any other B cell lymphomas, but is expressed by T cells and myeloids.
CD103 Also express CD11c, CD25 CD19, CD22 |
|
Viral association of LPL?
|
HCV in some places (with type II cryoglobulinemia)
|
|
Most common antibody in MGUS?
|
IgG (70%)
|
|
Things with MGUS that make it more likely to progress?
|
IgM or IgA (vs. IgG) and higher amount of plasma M protein.
|
|
Where do most extraosseous plasmacytomas occur?
|
In the upper respiratory tract.
|
|
Renal diseases associated with myeloma?
|
Cast nephropathy (myeloma kidney), amyloid, and light chain deposition disease (which is not amyloid)
|
|
Curious fact about antibiotic treatment for H. pylori?
|
MALT-associated with h. pylori has been known to go into remission with antibiotic treatment.
|
|
Most common site of MALT lymphoma?
|
Stomach
|
|
How does follicular lymphoma typically present?
|
With widespread disease.
|
|
Most common B cell lymphoma in the skin?
|
Primary cutaneous follicle center lymphoma
|
|
Difference between blastoid and pleomorphic mantle cell lymphoma?
|
Blastoid has blasty looking cells (open chromatin, prominent nucleoli) and a high mitotic rate. Pleomorphic cells are big and ugly and often polylobated.
|
|
Vessels seen in mantle cell lymphoma?
|
Pale, hyalnized vessels.
|
|
B cell lymphomas that are positive for CD10 and bcl-6?
|
Germinal center phenotype: follicular lymphoma and Burkitt lymphoma.
|
|
Common morphologic variants of DLBCL, NOS?
|
Centroblastic, immunoblastic, and anaplastic.
|
|
Commonest translocation in DLBCL, NOS?
|
Involves the bcl-6 gene on chr 3. DLBCL, NOS is usually bcl-6 positive.
|
|
How do you tell the difference between nodular lymphocyte predominent hodgkins and T-cell/histiocyte rich large B cell lymphoma?
|
T-cell rich B will have a lot of histiocytes.
T-cell rich B doesn't have T cells rosetting around the big cells. T-cell rich B doesn't have the follicular dendritic cell framework. |
|
IHC difference between primary cutaneous follicle center lymphoma and primary cutaneous DLBCL, leg type?
|
DLBCL leg type is often bcl-2 positive and the follicle center one is usually bcl-2 negative.
|
|
Other sites involved by lymphomatoid granulomatosis?
|
Lung and also brain, kidney, liver, and skin.
|
|
A large B cell lymphoma that is in the thymus only and no other lymph nodes or bone marrow?
|
Primary thymic (mediastinal) large B cell lymphoma.
|
|
Typical location for plasmablastic lymphoma?
|
Oral cavity, mucosal sites.
|
|
Gender predilection for Burkitt?
|
Males (2-3:1)
|
|
Types of Burkitt, clinically?
|
Endemic, sporadic, and immunodeficiency-associated.
|
|
EBV and Burkitt?
|
Usually seen in cases of endemic BL (along with malaria infection), less commonly in sporadic.
|
|
Burkitt and HIV?
|
Usually HIV+ patients develop BL with CD4 counts are still high, suggesting that it is not just immunosuppression alone.
|
|
Burkitt leukemia?
|
Rarely presents with predominantly PB invovlement, but may.
|
|
Lymphoma with medium-sized cells with squared-off borders?
|
Burkitt
|
|
What do the circulating prolymphocytes look like in T-prolymphocytic leukemia?
|
Medium with basophilic nongranular cytoplasm and chromatin that is coarse with a nucleolus. Cytoplasmic blebs are characteristic.
|
|
Prognosis for T-prolymphocytic leukemia?
|
Not good.
|
|
Prognosis of T cell large granular lymphocytic leukemia?
|
An indolent disease- morbidity comes from the anemia and neutropenia.
|
|
Type of T cell in MF?
|
CD4
|
|
Pattern of ALK staining in ALCL?
|
If they have the t(2;5) then nuclear AND cytoplasmic. Other translocations may show other patterns.
|
|
Most common cause of chronic benign lymphadenopathy in the US?
|
Cat scratch disease.
|
|
Cat scratch disease in the lymph node?
|
Subcapsular granulomas to stellate necrotic abscesses surrounded by palisading histiocytes.
|
|
Cells you may see in EBV lymphadenopathy?
|
Many immunoblasts that can have Reed-sternberg like features.
|
|
Who is prone to H. influenza infection in lymph nodes?
|
People who are susceptible to infections with encapsulated organisms (also, strep and staph), so agammaglobulinemia.
|
|
Associations of HHV8?
|
Kaposi's, primary effusion lymphoma, some multicentric castleman's. (8 the CKE)
|
|
Things that can cause a suppurative lymphadenitis?
|
Staph, cat scratch disease, and LGV
|
|
Things that can cause a necrotizing lymphadenitis?
|
Kikuchi, cat scratch, tularemia, anthrax, yersinia pestis (bubonic plague), typhoid fever.
|
|
Eosinophils in the lymph node, along with granulomas?
|
Allergic granulomatosis in lymph nodes.
|
|
Angiolymphoid hyperplasia with eosinophils?
|
Epithelioid hemangioma.
|
|
Symptoms of hyaline-vascular Castelman's disease?
|
Usually asymptomatic.
|
|
Treatment for solitary Castelman's disease?
|
Surgical excision.
|
|
Dermatopathic lymphadenitits?
|
Nodular, interfollicular/paracortical histiocytic expansions with some pigment.
|
|
Kawasaki disease, aka?
|
Mucocutaneous lymph node syndrome. Pharyngitis, lymphadenopathy, arthritis, skin rash, and coronary arteritis.
|
|
Where does Kimura disease affect?
|
Subcutaneous in the head and neck, salivary glands, and lymph nodes.
|
|
A systemic histiocytic disease that is CD1a negative?
|
Erdheim-chester disease.
|
|
Hallmark cells of ALPS?
|
CD45RO-, CD4/8- T cells.
|
|
What does the lymph node look like in Hyper-IgM syndrome?
|
There are primary follicles but no germinal centers.
|
|
Most important risk factor for EBV-drive PTLD?
|
EBV seronegativity at the time of transplant.
|
|
Organs with the highest incidence of PTLD?
|
Lung- high
Heart and liver- intermediate Kidney- low. |
|
When does EBV-positive PTLD tend to present?
|
In the era of cyclosporine, usually within the first year (EBV- tends to present later).
|
|
LPD associated with patients who have Crohn's disease taking infliximab?
|
Hepatosplenic T cell lymphoma.
|
|
Gender predilection in LCH?
|
Males (3.5:1)
|
|
Leukemia associated with LCH?
|
T lymphoblastic leukemia- the T cell receptor gene rearrangement is present in LCH cells.
|
|
Most specific feature for Castelman in LN?
|
Double germinal center. (also onion skinning and lollipop- vessels diving into germinal center).
|
|
Characteristic pattern of dermatopathic lymphadenitis?
|
Interfollicular expansion.
|
|
Funny thing about cells in Kikuchi?
|
Histiocytes: are crescentic and express MPO.
Neutrophils: excpetional in their absence (compared to the amount of necrosis) |
|
Cells you can see in ALPS?
|
T cells: CD4/8 negative and are naive (CD45+), yet cytotoxic (perforin, TIA).
B cells: CD5+ |
|
Syphillis in the lymph node?
|
Capsular fibrosis with infiltration by plasma cells and lymphocytes.
Rememember the obliterative endarteritis |
|
Stain that differentiates between interdigitating and follicular dendritic cells?
|
CD21
|
|
Angiolymphoid hyperplasia with eosinophilia vs. Kimura?
|
Kmura has LAD, peripheral hypereosinophilia, and increased IgE (and affects asian men) and ALH with E does not (and affects women usually).
|
|
Cells that are positive for naphthyl- ASD chloroacetate are?
|
Myeloids, mast cells, and macrophages.
|
|
Hairy cell leukemia often presents with?
|
Infections due to pancytopenia
|
|
Mechanism of resistance to Gleeved in CML?
|
May happen by mutations, overexpression of ABL/BCR, or reduced cellular uptake of drug.
|
|
Hodgkin's lymphoma most likely to transform to DLBCL?
|
Nodular lymphocyte predominant.
|
|
Hairy cell leukemia can be positive for which marker, commonly associated with another lymphoma?
|
Cyclin D1
|
|
Which feature is not seen in HIV lymphadenopathy?
|
I think it's capsular fibrosis (that's syphilis)- reactive follicular hyperplasia with serpentine follicles, plasma cells/mixed infiltrate with hypervascularity in the interfollicular zones, mantle cell invagination into the germinal centers, dermatopathic lymphadenitis.
|
|
M v F in follicular lymphoma?
|
1:1.7 (female predominance)
|
|
Pattern of LCH in the lymph node?
|
Sinusoidal pattern.
|
|
Status of T cell receptor in NK/T cell lymphoma?
|
Usually nonmutated, not rearranged.
|